# Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

> **NCT02629562** · PHASE1 · COMPLETED · sponsor: **Cinfa Biotech** · enrollment: 172 (actual)

## Conditions studied

- Clinical Pharmacology

## Interventions

- **BIOLOGICAL:** B12019 and Neulasta

## Key facts

- **NCT ID:** NCT02629562
- **Lead sponsor:** Cinfa Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** —
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629562, "Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02629562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*